Alzheimer's disease, one of the most common neurodegenerative diseases, is characterized by the gradual decline of cognitive function and the accumulation of beta-amyloid plaques and tau protein tangles in the brain. This disease, primarily affecting the elderly, has complex and multifactorial causes, including genetic, environmental, and inflammatory factors. Recent research has highlighted the significant role of the gut-brain-microbiota axis in the development and progression of neurological diseases like Alzheimer's.
The gut-brain-microbiota axis refers to the intricate network of communication between the brain, the gastrointestinal tract, and the gut microbiota (a community of microbes living in the gut). This axis connects the brain and gut through various mechanisms, including the immune system, nervous system, and microbiota-derived metabolites. Alterations in the composition of the gut microbiota can lead to systemic inflammation through increased gut permeability and immune system activation. This inflammation may weaken the blood-brain barrier, allowing harmful substances to enter the brain, ultimately leading to neurodegeneration and damage to brain cells.
In people with Alzheimer's disease, the composition of the gut microbiota is often different from that of healthy individuals. Research has shown that gut microbiota can contribute to the production or exacerbation of amyloid proteins, such as beta-amyloid. These proteins naturally exist in the brain and may have protective roles, but when their production is increased or they accumulate improperly, they form harmful plaques that contribute to neural damage.
Additionally, amyloid proteins produced by certain gut bacteria can trigger the misfolding and aggregation of brain proteins through a process called molecular mimicry. This process leads to neuroinflammation and the activation of microglia (immune cells in the brain), which further contribute to neuron damage and accelerate the progression of Alzheimer's disease.
One of the key factors in Alzheimer's progression is chronic inflammation, which often worsens with aging and changes in the gut microbiota composition. As people age, the diversity of their gut microbiota tends to decrease, leading to increased inflammation and reduced immune function. This chronic inflammation and immune system activation are directly linked to the onset and progression of Alzheimer's disease.
Studies have shown that modifying the gut microbiota composition through dietary changes or the intake of probiotics and prebiotics can improve brain health. Diets rich in fiber, antioxidants, and omega-3 fatty acids can help regulate inflammation and improve the functioning of the gut-brain axis. Additionally, probiotic supplements may increase gut microbiota diversity and thus help prevent neurodegenerative diseases like Alzheimer's.
Disruptions in the gut-brain-microbiota axis can be considered one of the contributing factors in the development and progression of Alzheimer's disease. Given the direct impact of gut microbiota on brain health and the immune system, altering gut microbiota composition and controlling inflammation through diet or probiotics may serve as preventive and even therapeutic approaches to reduce the risk and progression of Alzheimer's disease.